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Systematic Review: Individuals’ Goals for Surrogate
Decision-Making
Brenna Kelly, JD, MPH,* Annette Rid, MD,†‡ and David Wendler, PhD‡
OBJECTIVES: To determine to what extent current prac-
tice promotes the goals of individuals who did not desig-
nate a surrogate while competent with respect to decision-
making during periods of decisional incapacity.
DESIGN: Systematic literature search for studies published
in English and listed in PubMed, Scopus, Embase,
CINAHL, or PsycINFO. Studies were eligible if they
provided quantitative or qualitative empirical data on how
adults want treatment decisions to be made for them dur-
ing periods of incapacity.
SETTING: Primarily United States, with six other coun-
tries.
PARTICIPANTS: Fourteen qualitative articles, represent-
ing 11 distinct data sets, and 26 quantitative articles, rep-
resenting 25 distinct data sets, providing data on the views
of 22,828 individuals, met the inclusion criteria. Most of
the respondents were elderly or seriously ill.
MEASUREMENTS: Quantitative surveys and qualitative
interview studies assessing individuals’ goals.
RESULTS: The majority wanted close family members to
act as their surrogate. The most common reason for pre-
ferring family members was the belief that they know
which treatments the patient would want. Individuals also
wanted to reduce the burden on their families. There was
significant variation in the extent to which respondents
wanted their surrogates to have leeway when making
treatment decisions.
CONCLUSION: Individuals have three primary goals with
respect to making treatment decisions for them during peri-
ods of incapacity: involve their family, treat them consis-
tently with their own treatment preferences, and reduce the
burden on their family. Unfortunately, prior systematic
reviews have found that family members often are not able
to determine which treatment patients want, and family
members frequently experience substantial distress when
acting as surrogates. These findings suggest that current
practice frequently fails to promote individuals’ primary
goals for treatment decision-making. Future research should
evaluate ways to better promote individuals’ goals. In the
meantime, clinicians should be aware of these findings and
should encourage patients to document their own goals,
including their treatment preferences and their preferences
regarding how they want decisions to be made for them dur-
ing periods of decisional incapacity. J Am Geriatr Soc
60:884–895, 2012.
Key words: surrogate; end of life; decision-making;
incapacity; goals; preferences; values
Respect for autonomy implies that individuals shouldbe allowed to make their own treatment decisions,
typically in consultation with a clinician. Yet many people,
including the majority of those at the end of life, are not
able to make decisions.1–3 Moreover, the majority of indi-
viduals do not complete an advance directive or otherwise
leave clear instructions for how they want to be treated
during periods of decisional incapacity.4
Designated surrogates make decisions for incapacitated
individuals who completed a durable power of attorney
while competent. For incapacitated individuals who did not
designate a surrogate while competent, the next of kin
makes treatment decisions. Surrogates, whether patient des-
ignated or next of kin, are instructed to make decisions
based on the substituted judgment standard, making the
treatment decision they think the individual would have
made if he or she were capable.5,6 Proponents argue that this
approach extends individual autonomy by allowing individ-
uals’ preferences and values to guide how they are treated,
even when they are not able to make their own decisions.
No systematic analyses have attempted to identify
individuals’ goals with respect to treatment decision-mak-
ing during periods of incapacity. As a result, it is unclear
to what extent current practice promotes individuals’
goals. In the absence of an advance directive, how do indi-
viduals want treatment decisions to be made for them?
Does current practice of relying on the next of kin, and
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instructing them to use the substituted judgment standard,
promote individuals’ goals? To assess these questions, a
systematic review of the empirical literature was conducted
to evaluate how individuals want treatment decisions to be
made for them during periods of decisional incapacity.
METHODS
Data Sources and Searches
PubMed, Scopus, Embase, CINAHL, and PsycINFO were
searched for studies published in English that provide
quantitative or qualitative empirical data on how adults
want treatment decisions to be made for them during peri-
ods of decisional incapacity. Studies were eligible if they
were indexed before August 2, 2010. The search combined
Medical Subject Headings in three inclusion categories:
end-of-life care, attitudes, and family or surrogate. (See
Appendix for the specific terms used.)
Study Selection
The systematic search identified 6,551 articles, and the
authors identified seven additional articles. (See Figure 1
for the selection process.) Two authors independently
reviewed the titles of the articles and categorized them as
ineligible, of unclear eligibility, possibly eligible, or proba-
bly eligible. Categorization was performed while blinded
to the articles’ authors and affiliations. Articles were
judged to be ineligible only if the reviewer was confident,
based on the title, that the article would not satisfy the
inclusion criteria of providing quantitative or qualitative
empirical data by surveying adults regarding how they
want treatment decisions to be made for them during
periods of decisional incapacity. Titles that both authors
agreed clearly failed to satisfy these criteria were elimi-
nated, leaving 273 potentially eligible studies.
The same two authors read the abstracts (or first
pages of articles without abstracts) of the 273 articles and
Figure 1. Literature search and selection.
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ranked them as ineligible, of unclear eligibility, or likely
eligible. This process identified 54 articles as being of
unclear eligibility or likely eligible. Both authors indepen-
dently read the full text of these 54 articles and identified
33 articles that satisfied the inclusion criteria. Review of
the references of the 33 eligible articles yielded four addi-
tional eligible articles. The references of these four articles
were reviewed, yielding no additional eligible articles.
To determine whether the systematic search missed any
eligible articles, the two authors evaluated the references of
a related systematic review, which evaluated the effect of
making treatment decisions on surrogates.7 This review
identified three additional eligible articles. Review of the ref-
erences of these three articles yielded no additional eligible
articles. Finally, five researchers in the field were contacted
to determine whether they were aware of any eligible arti-
cles that had been missed, yielding no additional eligible
articles. Thus, in total, 40 articles met the inclusion criteria.
Data Extraction and Quality Assessment
Two authors independently read the 40 eligible articles
and extracted data on study location, number and type of
respondents, response rate, methods, main findings, and
limitations. When the extracted data from two different
articles appeared to be related, the corresponding authors
were contacted to determine whether the two articles were
based on the same data set.
Two authors assessed the methodological strength of
the eligible articles by giving them one point for each of 12
criteria that they satisfied. (See Table 1 for specific criteria.)
When a criterion was not mentioned in the article, it was
regarded as not satisfied. The final strength score is
intended to reflect the extent to which the articles provide
valid data relevant to the inclusion criteria used in the pres-
ent review.
The quantitative articles used a range of different
instruments, making it impossible to conduct formal statis-
tical analyses on the aggregate results. The reviewed data
are thus presented as a narrative summary.8
RESULTS
Identified Studies
The literature search identified 40 articles published in
English before August 2, 2010, that met the inclusion cri-
teria.9–48 These articles provided data from 36 distinct
data sets. The number of individuals evaluated in the arti-
cles ranged from 12 to 8,000, for a total of 22,828 indi-
viduals evaluated. Twenty articles reported the views of
elderly individuals, typically aged 65 and
older,14,15,17,18,20-24,26,27,29-31,33,36-38,42,44 nine reported the
views of terminally or seriously ill
patients.14,16,19,28,34,37,42,45,46 Ten articles focused on the
views of particular patient or ethnic
groups.9,25,29,30,32,35,40,41,47,48 Only six articles surveyed a
larger cross-section of a given population.10-13,39,43
The articles focused on whom individuals wanted to
be their surrogate if they could no longer make decisions
for themselves. Thirteen articles also evaluated why indi-
viduals preferred a particular surrogate; nine evaluated
how much leeway individuals thought that their surrogate
should have when making treatment decisions.
The first article was published in 1987; 22 articles
were published in 2000 or later. Twenty-nine of the
articles surveyed individuals in the United States; three
surveyed individuals in Canada; two each in France and
Japan; one each in Sweden, Australia, and Singapore; and
one in Japan and the United States. Twenty-six articles
reported quantitative data from 25 distinct data sets, and
14 reported qualitative data from 11 unique data sets
(Tables 2 and 3). The quantitative articles used a range of
instruments. Most of the qualitative articles used semi-
structured interviews. The qualitative articles reported data
using direct quotations, as well as general descriptors of
the results, such as a lot, some, and a little.
Who Individuals Want to Make Decisions for Them
The identified articles indicated that the vast majority of
respondents wanted close family members to make treat-
ment decisions for them during periods of decisional inca-
pacity (Tables 2 and 3). In six articles, most respondents
preferred their spouse to make decisions.11,13,18,36,37,44
Twelve articles reported that most respondents preferred
that their adult children act as surrogates.14,15,20–24,26,27,31,37,42
In one of these articles, individuals preferred their adult
children as decision-makers because they assumed that
their spouses would predecease them.42 A minority of
Table 1. Strength Criteria (Adapted from Ref. 7)
Quantitative studies
For each of the following criteria satisfied, a point was given
1. Trained interviewers
2. Interviewers independent of the care team
3. Selected a representative sample
4. Performed measures to ensure the reliability of the data
5. Performed measures to ensure the validity of the data
6. Evaluated why respondents selected a particular person or
process for end-of-life decision-making
7. Reported respondents’ sociodemographic characteristics
8. Response rate exceeded 50%
9. Reported the raw number or percentage of respondents for each
reported theme or result
10. Specified the number of participants needed to reach statistical
significance
11. Reached the specified number of participants
12. Statistical analysis of the findings
Qualitative studies
For each of the following criteria satisfied, a point was given
1. Trained interviewers
2. Interviewers independent of the care team
3. Selected a representative sample
4. Performed measures to ensure the reliability of the data
5. Performed measures to ensure the validity of the data
6. Evaluated why respondents selected a particular person or
process for end-of-life decision-making
7. Reported respondents’ sociodemographic characteristics
8. Response rate exceeded 50%
9. Reported the raw number or percentage of respondents for each
reported theme or result
10. Reported theme saturation
11. Recorded verbatim answers
12. Coded findings in a blind and independent manner
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respondents in the various articles preferred that a non-
family member and nonphysician make treatment deci-
sions.11,14,15,20–24,26,31,35,39 This preference sometimes
reflected the fact that the respondent did not have any
immediate family.20–22,26 In other cases, individuals did
not want their family members to be involved in making
decisions because of disagreements or conflicts they had
with their family.9,46
Fifteen articles, reporting the findings of 12 data sets,
found that the majority of respondents wanted their family
members to make decisions together.11,18–
22,28,30,34,38,42,43,45,47,48 One respondent identified as his
preferred decision-maker: “My wife, my son, and daugh-
ter. I am a firm believer that these are joint decisions.”20
Another stated that decisions should be made by “My
three daughters together…. They’d make them together.
They’d just stick together.”42 Most respondents wanted
their family members to consult with their clinicians dur-
ing the decision-making process.
Reasons for Surrogate Preference
Fourteen articles, reporting the findings of 11 data sets,
evaluated why respondents preferred a particular surro-
gate.12,14–16,20–22,29,33,38,42,46,47,48 Eleven of these articles
found that most individuals wanted a family member to be
their surrogate because the respondent assumed that family
members would know their treatment preferences.12,16,20–
22,29,33,42,4647,48 For example, one respondent explained
the preference for her daughter on the grounds that “My
daughter would choose what I would do in the situa-
tion.”46 In some cases, respondents’ confidence in their
family’s ability to determine their own treatment prefer-
ences was based on previous discussions between the
patient and family member: “I have talked to my son and
daughter. In all probability I’ll predecease them, so I
thought that was good enough.”22
Seventeen articles provided quantitative data regarding
whether respondents had any discussion with someone else
regarding end-of-life decision-making; none quantified the
frequency, length, or depth of discussion. 14,15,17,19,20,22–
26,30–32,41,42,45,46 Of these 17 articles, 11 found end-of-life
discussion rates of lower than
50%.14,15,17,19,26,30,32,41,42,45,46 An additional five articles
found rates lower than 70%.20,22–25 Only one reported
discussion rates higher than 70%.31
Ten articles found that respondents preferred family
members as surrogates based on trust.14,20–22,33,38,42,46–48
Some respondents trusted their family members to imple-
ment their wishes. For example, one respondent stated:
“You need someone you have confidence in to carry out
your wishes.”47 Others trusted their family members to
protect their interests: “My daughter would have my best
interest at heart.”46
How Much Leeway Do Individuals Want to Grant
Their Surrogates
Nine articles evaluated how much leeway individuals
thought their surrogates should have when making treat-
ment decisions for them.9,10,16,18,32,33,41,45,46 One of these
articles explicitly defined “leeway” as “freedom to do
what they think is best for you.”41 Another used the term
“leeway” without defining it.18 Two articles incorporated
some explanation of leeway in the question.9,10 For exam-
ple, one asked respondents: “How much leeway do you
want to give your proxies in interpreting your wishes?”9
The remaining five articles evaluated the concept without
using the term “leeway.”16,32,33,45,46 For example, one
article reported respondents’ views regarding “to what
extent their proxy should respect their treatment prefer-
ences.”32
These nine articles found that the preferred amount
of leeway varied widely. One quantitative article reported
that 58% of respondents wanted their surrogates to have
none or a little leeway, whereas 42% wanted their surro-
gates to have a lot or complete leeway.41 Another quanti-
tative article found that 63% of respondents wanted their
surrogates to follow their advance directives strictly or as
much as possible, whereas 33% wanted their surrogates
to use their advance directives as a reference only, and
3% did not care if their wishes were followed.32 The
qualitative articles, which found that some respondents
“granted permission to proxies to freely interpret their
written preferences,” whereas others insisted that their
surrogates “follow their instructions precisely,” supported
these findings.9
The reasons why respondents wanted their surrogates
to have leeway or not also varied. Many respondents who
wanted their wishes followed simply wanted to have some
treatments and avoid others. Others regarded the follow-
ing of their wishes as a way to avoid burdening their fam-
ily.9,10,18 One respondent stated: “follow my directions to
the T, because I do not want anyone to feel guilty that
they made the wrong decision.”9 Other respondents felt
that giving their surrogate leeway would allow the surro-
gate to make treatment decisions that better promoted the
patient’s interests.9,10,18
Study Strength
The median strength score of the identified articles was 7
out of 12 (range 2–10); 33 of the 40 articles scored 8
points or less. Several of the deficiencies are of particular
importance. For example, 15 articles did not report a
response rate, and five had response rates below 50%
(Tables 1–3).
Limitations
The present findings are subject to at least five important
limitations. First, the strength of the identified articles was
low, with a median strength score of 7 out of 12. Second,
only 13 articles, reporting the findings of 10 data sets,
asked respondents why they preferred a particular surro-
gate or a particular method for making treatment deci-
sions. Third, the studies were conducted in a range of
groups in different countries around the world. Thus, the
present data are not robust enough to detect significant dif-
ferences in views between groups and in different coun-
tries. Similarly, the wide range of survey instruments used
precludes subgroup analyses of the data. Fourth, the nine
articles that assessed leeway relied on different understand-
ings of the concept. Some understood leeway as flexibility
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in interpreting the individual’s stated preferences; others
understood leeway as the flexibility to make decisions that
were not consistent with the individual’s stated preferences.
Fifth, most respondents were older, very ill, or both.
Although this group of individuals represents those for
whom decisional incapacity is most likely, it may have
failed to detect differences based on age or generational
cohort.
DISCUSSION
Systematic review of the published data on more than
22,000 respondents from 36 unique data sets suggests that
individuals have three primary goals with respect to how
treatment decisions are made for them during periods of
decisional incapacity. First, the vast majority of individuals
want their close family members to make treatment deci-
sions, typically in consultation with the individual’s doc-
tors. Second, individuals want to be treated consistently
with their own preferences and values; most believe that
relying on their family to make decisions will promote this
goal. Third, many individuals want to minimize the bur-
den on their families.
In the absence of an advance directive, current prac-
tice relies on the next of kin to make treatment decisions
for incapacitated individuals. Yet prior systematic reviews
have found that family members often do not know
patients’ treatment preferences,49 and family members
often experience substantial burden when acting as surro-
gates.7 The present findings, when combined with those
of these prior systematic reviews, suggest that current
practice is promoting only one of individuals’ three pri-
mary goals with respect to decision-making during peri-
ods of incapacity. Current practice realizes individuals’
primary goal that close family members make treatment
decisions for them. Yet the way families currently make
decisions likely undermines individuals’ two other pri-
mary goals: receiving treatments they want and avoiding
burden on their families.
Implications for Future Research
Future research should assess whether modifications to
current practice, or alternative approaches, might better
promote individuals’ goals. In particular, future research
will be needed to assess whether it is possible to involve
family members in the decision-making process in ways
that reduce the burdens on them and also increase the
chances that individuals are treated consistent with their
own preferences and values.50
One approach that has gained considerable support is
shared decision-making, which involves family members
and clinicians making decisions together.51,52 Clinicians
may be able to help clarify the circumstances and options
and take on some responsibility for the ultimate decision.
Unfortunately, data suggest that clinicians may be less able
than family members to predict their patients’ treatment
preferences.53–55 Thus, greater involvement of clinicians in
the decision-making process may help to promote individ-
uals’ goal of reducing the burden on their family 7 while
undermining their goal of being treated consistently with
their own preferences.
A second approach that has been proposed is to pro-
vide family members with predictions for what treatment
course the individual would want based on the individuals’
sociodemographic characteristics.56,57 Future research will
be needed to evaluate whether this approach increases the
chances that individuals are treated consistently with their
preferences; whether it reduces the burden on their fami-
lies; and what patients think about this approach.
In addition to evaluating ways to promote all three of
individuals’ primary goals, future research should consider
how individuals prioritize these goals. Do individuals care
more about having their family involved in the decision-
making process, about reducing the burden on their fami-
lies, or about receiving the treatments they want? Answer-
ing this question will be especially important if future
research fails to identify approaches that successfully pro-
mote all three goals.
Implications for Clinical Practice
What implications do the present findings have for clinical
practice? First, clinicians should be aware that individuals
often assume that their family members know their treat-
ment preferences. Given that this often is not the case,49
clinicians should encourage individuals to discuss their
preferences with their designated surrogates and document
them using an advance directive. These steps may increase
the chances that at least individuals who have specific
treatment preferences are treated consistent with them.3 In
addition, the presence of an advance directive often
reduces the burden on surrogate decision-makers.7
Second, in addition to specific treatment preferences,
clinicians should encourage individuals to use their
advance directives to document any preferences they have
regarding how treatment decisions are made for them. To
what extent is the individual concerned primarily with the
treatments they receive versus who makes decisions for
them versus the effect on their families? This information
will help surrogate decision-makers to better respect indi-
viduals’ preferences.
Third, some commentators have argued that current
practice inappropriately directs surrogates to make the
decision they think the individual would have made if
capable.58 These commentators argue that surrogates
should instead have leeway to take into account consider-
ations other than the individual’s treatment preferences,
including the effect of the treatment options on the family.
Although the present findings suggest that many individu-
als want their surrogates to have substantial leeway, many
others do not. In addition, those who want their surro-
gates to have substantial leeway often assume that this
approach is more likely to result in their receiving the
treatments they want. In contrast, some respondents who
are concerned about the effect on their families want their
advance directives to be followed strictly because they
assume that this approach will reduce the burdens on their
family.
These findings suggest that it is not possible to develop
un unequivocal recommendation regarding how much lee-
way surrogates should have. In addition, simply asking
individuals to specify the amount of leeway they want
their surrogates to have may lead to confusion regarding
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the individual’s ultimate goals. To address this concern,
individuals could be encouraged to document their most
important goal with respect to making treatment decisions
for them during periods of decisional incapacity. Individ-
ual also might document how much leeway they want
their surrogates to have and the reasons for granting their
surrogates leeway or not.
CONCLUSION
Review of the published literature suggests that individuals
have three primary goals with respect to treatment deci-
sion-making during periods of decisional incapacity:
involve their family, being treated consistently with their
own preferences and values, and minimize the burden on
their family. In the absence of an advance directive, cur-
rent practice attempts to promote individuals’ goals by
relying on family members to make treatment decisions
using the substituted judgment standard. Yet previous
reviews show that family members often do not know the
individual’s treatment preferences49 and often experience
substantial burden when acting as surrogates.7 Clinicians
should be aware of these findings and encourage individu-
als to discuss and document their own goals, including any
specific treatment preferences and their preferences regard-
ing how they want decisions to be made for them. Future
research should consider whether modifications to current
practice or alternative approaches might better promote all
three of individuals’ primary goals with respect to deci-
sion-making during periods of incapacity.
ACKNOWLEDGMENTS
Thanks to Karen Smith for extensive assistance with the
literature search.
Conflict of Interest: The editor in chief has reviewed
the conflict of interest checklist provided by the authors
and has determined that the authors have no financial or
any other kind of personal conflicts with this paper.
The present work was completed as part of the
authors’ official duties as employees of the National Insti-
tutes of Health (NIH) Clinical Center. Annette Rid
gratefully acknowledges funding from the Swiss National
Science Foundation.
Author Contributions: AR and DW conceived of the
project. BK and DW collected the data. BK wrote the first
draft. BK, AR, and DW edited the draft. DW provided
supervision.
Sponsor’s Role: The present project was funded by the
Department of Bioethics, NIH Clinical Center. However,
the NIH had no role in the design, methods, subject
recruitment, data collections, analysis or preparation of
the paper.
REFERENCES
1. Raymont V, Bingley W, Buchanan A et al. Prevalence of mental incapacity
in medical inpatients and associated risk factors: Cross-sectional study.
Lancet 2004;364:1421–1427.
2. Prendergast TJ, Claessens MT, Luce JM. A national survey of end-of-life care
for critically ill patients. Am J Respir Crit CareMed 1998;158:1163–1167.
3. Silveira MJ, Kim SY, Langa KM. Advance directives and outcomes of sur-
rogate decision making before death. N Engl J Med 2010;362:1211–1218.
4. Fagerlin A, Schneider CE. Enough. The failure of the living will. Hastings
Cent Rep 2004;34:30–42.
5. Beauchamp TL, Childress JF. Principles of Biomedical Ethics, 6th Ed. New
York: Oxford University Press, 2009.
6. Buchanan AE, Brock DW. Deciding for Others: The Ethics of Surrogate
Decision Making. Cambridge, UK: Cambridge University Press, 1989.
7. Wendler D, Rid A. The effect on surrogates of making treatment decisions
for others. Ann Intern Med 2011;154:336–346.
8. Dixon-Woods M, Agarwal S, Jones D et al. Synthesizing qualitative and
quantitative evidence: A review of possible methods. J Health Serv Res Pol
2005;10:45–53.
9. Aikman PJ, Thiel EC, Martin DK et al. Proxy, health, and personal care
preferences: Implications for end-of-life care. Camb Q Healthc Ethics
1999;8:200–210.
10. Akabayashi A, Slingsby BT, Kai I. Perspectives on advance directives in
Japanese society: A population-based questionnaire survey. BMC Med Eth-
ics 2003;4:E5.
11. Azoulay E, Pochard F, Chevret S et al. Opinions about surrogate designa-
tion: A population survey in France. Crit Care Med 2003;31:1711–1714.
12. Beck A, Brown J, Boles M et al. Completion of advance directives by older
health maintenance organization members: The role of attitudes and beliefs
regarding life-sustaining treatment. J Am Geriatr Soc 2002;50:300–306.
13. Carr D, Khodyakov D. Health care proxies: Whom do young old adults
choose and why? J Health Soc Behav 2007;48:180–194.
14. Cohen-Mansfield JC, Droge JA, Billig N. The utilization of the durable
power of attorney for health care among hospitalized elderly patients.
J Am Geriatr Soc 1991;39:1174–1178.
15. Cohen-Mansfield J, Rabinovich BA, Lipson S et al. The decision to execute
a durable power of attorney for health care and preferences regarding the
utilization of life-sustaining treatments in nursing home residents. Arch
Intern Med 1991;151:289–294.
16. Eliott J, Olver I. Autonomy and the family as (in)appropriate surrogates
for DNR decisions: A qualitative analysis of dying cancer patients’ talk.
J Clin Ethics 2007;18:206–218.
17. Gamble ER, McDonald PJ, Lichstein PR. Knowledge, attitudes, and behav-
ior of elderly persons regarding living wills. Arch Intern Med
1991;151:277–280.
18. Hawkins NA, Ditto PH, Danks JH et al. Micromanaging death: Process
preferences, values, and goals in end-of-life medical decision making. Ger-
ontologist 2005;45:107–117.
19. Heyland D, Frank C, Groll D et al. Understanding cardiopulmonary resus-
citation decision making: Perspectives of seriously ill hospitalized patients
and family members. Chest 2006;130:419–428.
20. High DM. All in the family: Extended autonomy and expectations in surro-
gate health care decision-making. Gerontologist 1988;28:46–50.
21. High DM, Turner HB. Surrogate decision-making: The elderly’s familial
expectations. Theor Med 1987;8:303–320.
22. High DM. Who will make health care decisions for me when I can’t?
J Aging Health 1990;2:291–309.
23. High DM. Advance directives and the elderly: A study of intervention strat-
egies to increase use. Gerontologist 1993;33:342–349.
24. High DM. Why are elderly people not using advance directives? J Aging
Health 1993;5:497–515.
25. Hines SC, Glover JJ, Holley JL et al. Dialysis patients’ preferences for fam-
ily-based advance care planning. Ann Intern Med 1999;130:825–828.
26. Hopp FP. Preferences for surrogate decision makers, informal communica-
tion, and advance directives among community-dwelling elders: Results
from a national study. Gerontologist 2000;40:449–457.
27. Hornung CA, Eleazer GP, Strothers HS et al. Ethnicity and decision-mak-
ers in a group of frail older people. J Am Geriatr Soc 1998;46:280–286.
28. Kim SH, Kjervik D. Deferred decision making: Patients’ reliance on family
and physicians for CPR decisions in critical care. Nurs Ethics 2005;12:493
–506.
29. Low JA, Ng WC, Yap KB et al. End-of-life issues: Preferences and choices
of a group of elderly Chinese subjects attending a day care centre in Singa-
pore. Ann Acad Med Singapore 2000;29:50–56.
30. Matsumura S, Bito S, Liu H et al. Acculturation of attitudes toward end-
of-life care. J Gen Intern Med 2002;17:531–539.
31. Meier DE, Gold G, Mertz K et al. Enhancement of proxy appointment for
older persons: Physician counseling in the ambulatory setting. J Am Geriatr
Soc 1996;44:37–43.
32. Miyata H, Shiraishi H, Kai I. Survey of the general public’s attitudes
toward advance directives in Japan: How to respect patients’ preferences.
BMC Med Ethics 2006;7:E11.
33. Moore CD, Sparr J, Sherman S et al. Surrogate decision-making: Judg-
ment standard preferences of older adults. Soc Work Health Care
2003;37:1–16.
894 KELLY ET AL. MAY 2012–VOL. 60, NO. 5 JAGS
34. Nolan MT, Hughes M, Narendra DP et al. When patients lack capacity:
The roles that patients with terminal diagnoses would choose for their
physicians and loved ones in making medical decisions. J Pain Symptom
Manage 2005;30:342–353.
35. Norris WM, Nielsen EL, Engelberg RA et al. Treatment preferences for
resuscitation and critical care among homeless persons. Chest
2005;127:2180–2187.
36. Patterson SL, Baker M, Maeck JP. Durable powers of attorney: Issues of
gender and health care decision-making. J Gerontol Soc Work 1993;21:161
–177.
37. Puchalski CM, Zhong Z, Jacobs MM et al. Patients who want their family
and physician to make resuscitation decisions for them: Observations from
SUPPORT and HELP. J Am Geriatr Soc 2000;48:S84–S90.
38. Rosenfeld KE, Wenger NS, Kagawa-Singer M. End-of-life decision making:
A qualitative study of elderly individuals. J Gen Intern Med 2000;15:620–
625.
39. Roupie E, Santin A, Boulme R et al. Patients’ preferences concerning medi-
cal information and surrogacy: Results of a prospective study in a French
emergency department. Intensive Care Med 2000;26:52–56.
40. Searight HR, Gafford J. “It’s like playing with your destiny”: Bosnian
immigrants’ views of advance directives and end-of-life decision-making.
J Immigr Health 2005;7:195–203.
41. Sehgal A, Galbraith A, Chesney M et al. How strictly do dialysis patients
want their advance directives followed? JAMA 1992;267:59–63.
42. Shawler C, High DM, Moore KK et al. Surrogate decision making for hos-
pitalized elders. J Gerontol Nurs 1992;18:5–11.
43. Sjokvist P, Nilstum T, Svantesson M et al. Withdrawal of life support—
who should decide? Intensive Care Med 1999;25:949–954.
44. Sloan JP. Advance directives: Patient preferences in family practice. Can
Fam Physician 1990;36:876–878.
45. Sulmasy DP, Hughes MT, Thompson RE et al. How would terminally ill
patients have others make decisions for them in the event of decisional
incapacity? A longitudinal study. J Am Geriatr Soc 2007;55:1981–1988.
46. Terry PB, Vettese M, Song J et al. End-of-life decision making: When
patients and surrogates disagree. J Clin Ethics 1999;10:286–293.
47. Waters CM. Understanding and supporting African Americans’ perspectives
of end-of-life care planning and decision making. Qual Health Res
2001;11:383–398.
48. Waters CM. End-of-Life care directives among African Americans: Lessons
learned—a need for community-centered discussion and education. J Com-
munity Health Nurs 2000;17:25–37.
49. Shalowitz D, Garrett-Mayer E, Wendler D. The accuracy of surrogate deci-
sion-makers: A systematic review. Arch Intern Med 2006;166:493–497.
50. Rid A, Wendler D. Can we improve medical treatment decision-making for
incapacitated patients? Hastings Cent Rep 2010;40:36–45.
51. Davidson JE, Powers K, Hedayat KM et al. Clinical practice guidelines for
support of the family in the patient-centered intensive care unit: American
College of Critical Care Medicine Task Force 2004–2005. Crit Care Med
2007;35:605–622.
52. Thompson BT, Cox PN, Antonelli M et al. Challenges in end-of-life care
in the ICU: Statement of the 5th International Consensus Conference in
Critical Care: Brussels, Belgium, April 2003: Executive summary. Crit Care
Med 2004;32:1781–1784.
53. Uhlmann RF, Pearlman RA, Cain KC. Physicians’ and spouses’ predictions
of elderly patients’ resuscitation preferences. J Gerontol 1988;43:M115–
M121.
54. Fischer GS, Tuslky JA, Rose MR et al. Patient knowledge and physician
predictions of treatment preferences after discussion of advance directives.
J Gen Intern Med 1998;13:447–454.
55. Coppola KM, Ditto PH, Danks JH et al. Accuracy of primary care and
hospital-based physicians’ predictions of elderly outpatients’ treatment pref-
erences with and without advance directives. Arch Intern Med
2001;161:431–440.
56. Rid A, Wendler D. Use of a patient preference predictor to help make med-
ical decisions for incapacitated patients. J Med Phil in press.
57. Rid A, Wendler D. Treatment decision making for incapacitated patients:
Is development and use of a patient preference predictor feasible? J Med
Phil in press.
58. Berger JT, DeRenzo EG, Schwartz J. Surrogate decision making: Reconcil-
ing ethical theory and clinical practice. Ann Intern Med 2008;149:48–53.
APPENDIX
SEARCH TERMS
The search terms were: Advance care planning [Medical
Subject Headings] or advance directives [Medical Subject
Headings] or advance directive adherence [Medical Subject
Headings] or resuscitation orders [Medical Subject Head-
ings] or withholding treatment [Medical Subject Headings]
or treatment refusal [Medical Subject Headings] or Critical
Care [Medical Subject Headings] or Intensive Care [Medi-
cal Subject Headings] or Life Support Care [Medical
Subject Headings] or Palliative Care [Medical Subject
Headings] or Terminal Care or resuscitation [Medical Sub-
ject Headings] or “end-of-life” [tw] AND Proxy [Medical
Subject Headings] or legal guardians [Medical Subject
Headings] or third-party consent [Medical Subject Head-
ings] or family [major] or caregivers [Medical Subject
Headings] or surrog* [tw] or mental competency [Medical
Subject Headings] or “durable power of attorney” [tw]
AND Choice* [Title] or prefer* [Title] or goal* [Title] or
desire* [Title] or wish* [Title] or attitude* [Title] or values
[Title] or communication [Medical Subject Headings] or
decision-making [Medical Subject Headings].
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